High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells

Virology

Volumn 444, Issue 1-2, 2013, Pages 257-262

  Iijima, Norifumi ^a   Goodwin, Edward C ^a   DiMaio, Daniel ^a   Iwasaki, Akiko ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; Dendritic cell; Immune evasion; Monocytes

Indexed keywords

PROTEIN E6;

ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVITY; CELL ASSAY; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOCYTOSIS; GROWTH INHIBITION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; LANGERHANS CELL; MOLECULAR DYNAMICS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; WART VIRUS;

CERVICAL CANCER; DENDRITIC CELL; IMMUNE EVASION; MONOCYTES;

CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HUMANS; IMMUNE EVASION; LANGERHANS CELLS; MONOCYTES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84882847842     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.06.020     Document Type: Article

References (29)

1. Connor J.P., Ferrer K., Kane J.P., Goldberg J.M. Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol. Oncol. 1999, 75(1):130-135. Oct.
2. DeFilippis R.A., Goodwin E.C., Wu L., DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 2003, 77(2):1551-1563. Jan.
3. Doorbar J. The papillomavirus life cycle. J. Clin. Virol.: the official publication of the Pan American Society for Clinical Virology 2005, 32(Suppl. 1). S7-15.
4. Gainey M.D., Rivenbark J.G., Cho H., Yang L., Yokoyama W.M., Viral M.H.C. class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming. Proc. Nat. Acad. Sci. U.S.A. 2012, 109(47):E3260-E3267. Nov 20.
5. Geissmann F., Prost C., Monnet J.P., Dy M., Brousse N., Hermine O. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 1998, 187(6):961-966. Mar 16.
6. Ginhoux F., Tacke F., Angeli V., Bogunovic M., Loubeau M., Dai X.M., et al. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 2006, 7(3):265-273. Mar.
7. Goodwin E.C., DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Nat. Acad. Sci. U.S.A. 2000, 97(23):12513-12518. Nov 7.
8. Goodwin E.C., Yang E., Lee C.J., Lee H.W., DiMaio D., Hwang E.S. Rapid induction of senescence in human cervical carcinoma cells. Proc. Nat. Acad. Sci. U.S.A. 2000, 97(20):10978-10983. Sep 26.
9. Guess J.C., McCance D.J. Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J. Virol. 2005, 79(23):14852-14862. Dec.
10. Hayati A.R., Zulkarnaen M. An immunohistochemical study of CD1a and CD83-positive infiltrating dendritic cell density in cervical neoplasia. Int. J. Gynecol. Pathol 2007, 26(1):83-88. Jan.
11. Huang S.-M., McCance D.J. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J. Virol. 2002, 76(17):8710-8721. September 1, 2002.
12. Hubert P., Caberg J.H., Gilles C., Bousarghin L., Franzen-Detrooz E., Boniver J., et al. E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol 2005, 206(3):346-355. Jul.
13. Hughes R.G., Norval M., Howie S.E. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia. J. Clin. Pathol 1988, 41(3):253-259. Mar.
14. Iijima N., Linehan M.M., Zamora M., Butkus D., Dunn R., Kehry M.R., et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J. Exp. Med. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't] 2008, 205(13):3041-3052. Dec 22.
15. Jeon S., Lambert P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Nat. Acad. Sci. U.S.A. 1995, 92(5):1654-1658. Feb 28.
16. Jimenez-Flores R., Mendez-Cruz R., Ojeda-Ortiz J., Munoz-Molina R., Balderas-Carrillo O., de la Luz Diaz-Soberanes M., et al. High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract. Immunology 2006, 117(2):220-228. Feb.
17. Kleine-Lowinski K., Rheinwald J.G., Fichorova R.N., Anderson D.J., Basile J., Munger K., et al. Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. Int. J. Cancer 2003, 107(3):407-415. Nov 10.
18. Le Poole I.C., Elmasri W.M., Denman C.J., Kroll T.M., Bommiasamy H., Lyons Eiben G., et al. Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells. Cancer Immunol. Immunother 2008, 57(6):789-797. Jun.
19. Magaldi T.G., Almstead L.L., Bellone S., Prevatt E.G., Santin A.D., DiMaio D. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology 2012, 422(1):114-124. Jan 5.
20. Matthews K., Leong C.M., Baxter L., Inglis E., Yun K., Backstrom B.T., et al. Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J. Virol. 2003, 77(15):8378-8385. Aug.
21. Merad M., Manz M.G., Karsunky H., Wagers A., Peters W., Charo I., et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 2002, 3(12):1135-1141. Dec.
22. Moody C.A., Laimins L.A. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 2010, 10(8):550-560. Aug.
23. Terlou A., van Seters M., Kleinjan A., Heijmans-Antonissen C., Santegoets L.A., Beckmann I., et al. Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia. Int. J. Cancer 2010, 127(12):2831-2840. Dec 15.
24. Uchimura N.S., Ribalta J.C., Focchi J., Simoes M.J., Uchimura T.T., Silva E.S. Evaluation of Langerhans' cells in human papillomavirus-associated squamous intraepithelial lesions of the uterine cervix. Clin. Exp. Obstet. Gynecol 2004, 31(4):260-262.
25. Viac J., Guerin-Reverchon I., Chardonnet Y., Bremond A. Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: correlation with human papillomavirus infection. Immunobiology 1990, 180(4-5):328-338. Jun.
26. Wakim L.M., Waithman J., van Rooijen N., Heath W.R., Carbone F.R. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008, 319(5860):198-202. Jan 11.
27. Zammit D.J., Lefrancois L. Dendritic cell-T cell interactions in the generation and maintenance of CD8 T cell memory. Microb. Infect 2006, 8(4):1108-1115. Apr.
28. Zammit D.J., Cauley L.S., Pham Q.M., Lefrancois L. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 2005, 22(5):561-570. May.
29. zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009, 384(2):260-265. Feb 20.